Table 1 Stage 1 patient baseline characteristics.

From: Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC)

 

Age 2–<6 years

(n = 9)

Age 6–<12 years

(n = 9)

Age 12–<18 years

(n = 9)

Age [years], mean ± SD

3.1 ± (1.2)

8.8 ± 1.7

15.3 ± 1.1

Male, n (%)

2 (22)

7 (78)

3 (33)

Race, n (%)

  White

8 (89)

9 (100)

8 (89)

  Asian

1 (11)

0

1(11)

Ethnicity, n (%)

  Hispanic or Latino

0

0

0

  Not Hispanic or Latino

7 (78)

9 (100)

8 (89)

  Not reported

2 (22)

0

1 (11)

Tumor type, n (%)

  Ewing’s sarcoma

0

3 (33)

3 (33)

  Hodgkin’s lymphoma

0

0

3 (33)

  Medulloblastoma

0

0

0

  Neuroblastoma

7 (78)

4 (44)

2 (22)

  Non-Hodgkin’s lymphoma

0

1 (11)

0

  Rhabdomyosarcoma

1 (11)

0

1 (11)

  PNET

1 (11)

0

0

  CNS tumor not germinomatous

0

1 (11)

0

Back to article page